Artra Group Corporation
TSE:6029.T
139 (JPY) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 4,497.601 | 4,671.498 | 3,158.24 | 2,426.748 | 2,833.781 | 3,479.2 | 3,759.158 | 3,251.564 | 2,564.07 | 1,490.027 | 1,320.152 |
| Cost of Revenue
| 3,057.392 | 3,099.204 | 2,281.994 | 1,928.289 | 1,879.085 | 2,279.498 | 2,390.049 | 2,007.888 | 1,539.112 | 908.46 | 764.447 |
| Gross Profit
| 1,440.209 | 1,572.294 | 876.246 | 498.459 | 954.696 | 1,199.702 | 1,369.109 | 1,243.676 | 1,024.958 | 581.567 | 555.705 |
| Gross Profit Ratio
| 0.32 | 0.337 | 0.277 | 0.205 | 0.337 | 0.345 | 0.364 | 0.382 | 0.4 | 0.39 | 0.421 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 134 | 136 | 122 | 173 | 173 | 157 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 1,249.797 | 1,399.861 | 936.948 | 685.196 | 712.506 | 798.819 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 1,383.797 | 1,535.861 | 1,058.948 | 858.196 | 885.506 | 955.819 | 893.449 | 923.484 | 625.38 | 0 | 0 |
| Other Expenses
| -5.184 | 1,569.47 | 1,099.267 | 908.619 | 929.498 | 20.75 | 20.605 | 9.703 | 71.305 | -7.059 | 5.698 |
| Operating Expenses
| 1,388.981 | 1,569.47 | 1,099.267 | 908.619 | 929.498 | 1,035.421 | 933.535 | 949.769 | 637.542 | 503.564 | 411.388 |
| Operating Income
| 51.228 | 15.096 | -223.022 | -410.161 | 38.65 | 164.28 | 435.573 | 293.905 | 387.415 | 78.002 | 144.316 |
| Operating Income Ratio
| 0.011 | 0.003 | -0.071 | -0.169 | 0.014 | 0.047 | 0.116 | 0.09 | 0.151 | 0.052 | 0.109 |
| Total Other Income Expenses Net
| 22.152 | 11.76 | -108.231 | -0.351 | -101.771 | 439.618 | 12.173 | -44.52 | 65.897 | -33.574 | 0.139 |
| Income Before Tax
| 73.38 | 26.856 | -331.253 | -410.512 | -63.121 | 603.899 | 447.747 | 249.387 | 453.313 | 44.429 | 144.456 |
| Income Before Tax Ratio
| 0.016 | 0.006 | -0.105 | -0.169 | -0.022 | 0.174 | 0.119 | 0.077 | 0.177 | 0.03 | 0.109 |
| Income Tax Expense
| 19.414 | 24.751 | 19.868 | 30.251 | 83.543 | 333.968 | 146.316 | 100.684 | 184.578 | 16.825 | -1.085 |
| Net Income
| 53.966 | 2.104 | -351.121 | -440.763 | -146.664 | 269.93 | 301.43 | 148.703 | 268.734 | 27.604 | 145.542 |
| Net Income Ratio
| 0.012 | 0 | -0.111 | -0.182 | -0.052 | 0.078 | 0.08 | 0.046 | 0.105 | 0.019 | 0.11 |
| EPS
| 5.43 | 0.22 | -36.76 | -49.87 | -16.71 | 30.88 | 34.59 | 18.41 | 34.45 | 4.76 | 25.53 |
| EPS Diluted
| 5.43 | 0.22 | -36.76 | -49.87 | -16.71 | 30.39 | 34.03 | 17.09 | 31.9 | 4.74 | 25.53 |
| EBITDA
| 191.345 | 162.098 | -61.855 | -221.39 | 174.274 | 304.307 | 561.868 | 374.747 | 506.002 | 104.037 | 181.834 |
| EBITDA Ratio
| 0.043 | 0.035 | -0.02 | -0.091 | 0.061 | 0.087 | 0.149 | 0.115 | 0.197 | 0.07 | 0.138 |